BitFrontier Capital Holdings, Inc. Appoints New CEO to Spearhead Strategic Turnaround

BitFrontier Capital Holdings, Inc. (OTC: BFCH) has appointed Dr. Jordan P. Balencic as its Chief Executive Officer, marking a pivotal step in the company's strategic turnaround. Dr. Balencic, a physician entrepreneur with extensive experience in the health and wellness sector, is set to lead BFCH through a comprehensive transformation aimed at realigning its capital structure, business model, and shareholder value proposition.

The company's strategic plan under Dr. Balencic's leadership includes retiring over $2 million in legacy convertible note obligations to improve its capital structure. BFCH is pivoting its business model towards consumer health innovation, focusing on functional foods, nootropic beverages, supplements, and digital health technologies. A full rebranding initiative is underway to reflect this new strategic direction.

Further steps include optimizing the capital structure by streamlining the share count and assembling a new Board of Directors to support the transition. BFCH also intends to pursue OTCQB qualification in 2026, aiming to enhance investor confidence and access to institutional capital. Dr. Balencic emphasized the company's commitment to discipline, transparency, and long-term strategy in rebuilding BFCH into a credible, innovation-focused public company.